I don't see any reason there. Over all, GILD is already in lower end of the valuation with it's current P/E. I had never recall they are in such low P/E in past, it is pure caused by market playing down. Compare to other BioPham, I think this stock is no where to go but up. so don't be disturbed by daily fluctuation as many institution investors are in and out for day trading.